Literature DB >> 16198028

Baboon as a nonhuman primate model for vaccine studies.

Krishna K Murthy1, Mary T Salas, Kenneth D Carey, Jean L Patterson.   

Abstract

Nonhuman primates are suitable and valid models to determine the safety, immunogenicity and efficacy of candidate vaccines that are being developed for human application. Among the nonhuman primates, baboons have been found to be ideal for vaccine studies because they are phylogenetically closer to humans, have a similar immune system and response and are available in large numbers. During the last two decades, numerous candidate vaccines have been evaluated in the baboon model.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16198028     DOI: 10.1016/j.vaccine.2005.08.047

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  17 in total

Review 1.  Animal Models of Ebolavirus Infection.

Authors:  Marisa C St Claire; Dan R Ragland; Laura Bollinger; Peter B Jahrling
Journal:  Comp Med       Date:  2017-06-01       Impact factor: 0.982

2.  Age-associated alteration in innate immune response in captive baboons.

Authors:  Dianne McFarlane; Roman F Wolf; Kristen A McDaniel; Gary L White
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2011-08-22       Impact factor: 6.053

3.  Development of a novel preclinical model of pneumococcal pneumonia in nonhuman primates.

Authors:  Bryan D Kraft; Claude A Piantadosi; Ashlee M Benjamin; Joseph E Lucas; Aimee K Zaas; Marisol Betancourt-Quiroz; Christopher W Woods; Alan L Chang; Victor L Roggli; Craig D Marshall; Geoffrey S Ginsburg; Karen Welty-Wolf
Journal:  Am J Respir Cell Mol Biol       Date:  2014-05       Impact factor: 6.914

4.  An age-old paradigm challenged: old baboons generate vigorous humoral immune responses to LcrV, a plague antigen.

Authors:  Sue Stacy; Amanda Pasquali; Valerie L Sexton; Angelene M Cantwell; Ellen Kraig; Peter H Dube
Journal:  J Immunol       Date:  2008-07-01       Impact factor: 5.422

5.  The effect of season on inflammatory response in captive baboons.

Authors:  Dianne McFarlane; Roman F Wolf; Kristen A McDaniel; Gary L White
Journal:  J Med Primatol       Date:  2012-08-21       Impact factor: 0.667

6.  Robust immunity to an auxotrophic Mycobacterium bovis BCG-VLP prime-boost HIV vaccine candidate in a nonhuman primate model.

Authors:  Gerald K Chege; Wendy A Burgers; Helen Stutz; Ann E Meyers; Rosamund Chapman; Agano Kiravu; Rubina Bunjun; Enid G Shephard; William R Jacobs; Edward P Rybicki; Anna-Lise Williamson
Journal:  J Virol       Date:  2013-02-28       Impact factor: 5.103

7.  Age- and gender-associated changes in the concentrations of serum TGF-1β, DHEA-S and IGF-1 in healthy captive baboons (Papio hamadryas anubis).

Authors:  E L Willis; R F Wolf; G L White; D McFarlane
Journal:  Gen Comp Endocrinol       Date:  2013-10-23       Impact factor: 2.822

Review 8.  Experimental vaccines in animal models for schistosomiasis.

Authors:  Afzal A Siddiqui; Gul Ahmad; Raymond T Damian; Ronald C Kennedy
Journal:  Parasitol Res       Date:  2008-02-08       Impact factor: 2.289

Review 9.  Comparison of the immunogenicity & protective efficacy of various SARS-CoV-2 vaccine candidates in non-human primates.

Authors:  Labanya Mukhopadhyay; Pragya D Yadav; Nivedita Gupta; Sreelekshmy Mohandas; Deepak Y Patil; Anita Shete-Aich; Samiran Panda; Balram Bhargava
Journal:  Indian J Med Res       Date:  2021 Jan & Feb       Impact factor: 2.375

Review 10.  The Baboon (Papio spp.) as a model of human Ebola virus infection.

Authors:  Donna L Perry; Laura Bollinger; Gary L White
Journal:  Viruses       Date:  2012-10-23       Impact factor: 5.048

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.